These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27978985)

  • 21. Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.
    Suhara T; Chaki S; Kimura H; Furusawa M; Matsumoto M; Ogura H; Negishi T; Saijo T; Higuchi M; Omura T; Watanabe R; Miyoshi S; Nakatani N; Yamamoto N; Liou SY; Takado Y; Maeda J; Okamoto Y; Okubo Y; Yamada M; Ito H; Walton NM; Yamawaki S
    Int J Neuropsychopharmacol; 2017 Apr; 20(4):285-294. PubMed ID: 28031269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery.
    McArthur RA
    Neurosci Biobehav Rev; 2017 May; 76(Pt A):4-21. PubMed ID: 28434587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translational bioinformatics in psychoneuroimmunology: methods and applications.
    Yan Q
    Methods Mol Biol; 2012; 934():383-400. PubMed ID: 22933157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine biomarkers in the early stages of diseases: current status and perspective.
    Jing J; Gao Y
    Discov Med; 2018 Feb; 25(136):57-65. PubMed ID: 29579412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applying systems biology in drug discovery and development.
    Galizzi JP; Lockhart BP; Bril A
    Drug Metabol Drug Interact; 2013; 28(2):67-78. PubMed ID: 23612649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Biomarkers on Personalized Medicine.
    Carrigan P; Krahn T
    Handb Exp Pharmacol; 2016; 232():285-311. PubMed ID: 26330258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From biomarker strategies to biomarker activities and back.
    van Gool AJ; Henry B; Sprengers ED
    Drug Discov Today; 2010 Feb; 15(3-4):121-6. PubMed ID: 19931413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bridging the translational innovation gap through good biomarker practice.
    van Gool AJ; Bietrix F; Caldenhoven E; Zatloukal K; Scherer A; Litton JE; Meijer G; Blomberg N; Smith A; Mons B; Heringa J; Koot WJ; Smit MJ; Hajduch M; Rijnders T; Ussi A
    Nat Rev Drug Discov; 2017 Sep; 16(9):587-588. PubMed ID: 28450744
    [No Abstract]   [Full Text] [Related]  

  • 29. Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline.
    Kelm JM; Lal-Nag M; Sittampalam GS; Ferrer M
    Drug Discov Today; 2019 Jan; 24(1):26-30. PubMed ID: 30071313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform.
    Vaudano E; Vannieuwenhuyse B; Van Der Geyten S; van der Lei J; Visser PJ; Streffer J; Ritchie C; McHale D; Lovestone S; Hofmann-Apitius M; Truyen L; Goldman M
    Alzheimers Dement; 2015 Sep; 11(9):1121-2. PubMed ID: 25754460
    [No Abstract]   [Full Text] [Related]  

  • 31. ALS biomarkers for therapy development: State of the field and future directions.
    Benatar M; Boylan K; Jeromin A; Rutkove SB; Berry J; Atassi N; Bruijn L
    Muscle Nerve; 2016 Feb; 53(2):169-82. PubMed ID: 26574709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to Address Challenges in Neuroscience Drug Discovery and Development.
    O'Donnell P; Rosen L; Alexander R; Murthy V; Davies CH; Ratti E
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):445-448. PubMed ID: 31139821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation.
    Salter H; Holland R
    J Intern Med; 2014 Sep; 276(3):215-28. PubMed ID: 24605903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.
    Shoemaker LD; Achrol AS; Sethu P; Steinberg GK; Chang SD
    Neurosurgery; 2012 Mar; 70(3):518-25. PubMed ID: 21866062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From bench to MS bedside: challenges translating biomarker discovery to clinical practice.
    Rajasekharan S; Bar-Or A;
    J Neuroimmunol; 2012 Jul; 248(1-2):66-72. PubMed ID: 22381245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Translational research in drug discovery - current issues and perspectives].
    Fujita Y; Hanada Y; Sayama H; Inami M; Fujimura T; Sudoh K
    Nihon Yakurigaku Zasshi; 2016; 148(6):296-301. PubMed ID: 27904007
    [No Abstract]   [Full Text] [Related]  

  • 38. Toward an integrated pipeline for protein biomarker development.
    Drabovich AP; Martínez-Morillo E; Diamandis EP
    Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research.
    Heilig M; Sommer WH; Spanagel R
    Curr Top Behav Neurosci; 2016; 28():151-71. PubMed ID: 27240677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [From biomarkers to clinical decision support].
    Antal P; Reiter J; Mátyus P
    Orv Hetil; 2015 Dec; 156(51):2077-81. PubMed ID: 26654544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.